五月天精品视频播放在线观看_欧美精品国产一区二区_九九99久久精品免费观看_欧美精品专区第1页_亚洲最大日夜无码中文字幕_玖玖无码中文字幕五月天_欧美裸身美女_91亚洲无码有码在线观看,91亚洲精品久久久蜜桃网站,HD老熟女BBN老淑女,免费亚洲婷婷

歡迎來到北京博奧森生物技術(shù)有限公司網(wǎng)站!
咨詢熱線

18611424007

當(dāng)前位置:首頁  >  新聞資訊  >  【12月文獻(xiàn)戰(zhàn)報】Bioss抗體新增高分文獻(xiàn)精彩呈現(xiàn)

【12月文獻(xiàn)戰(zhàn)報】Bioss抗體新增高分文獻(xiàn)精彩呈現(xiàn)

更新時間:2023-01-12  |  點(diǎn)擊率:1287

 


截至目前,引用Bioss產(chǎn)品發(fā)表的文獻(xiàn)共23200篇,總影響因子106190.49分,發(fā)表在Nature, Science, Cell以及Immunity等頂級期刊的文獻(xiàn)共54篇,合作單位覆蓋了清華、北大、復(fù)旦、華盛頓大學(xué)、麻省理工學(xué)院、東京大學(xué)以及紐約大學(xué)等國際研究機(jī)構(gòu)上百所。

我們每月收集引用Bioss產(chǎn)品發(fā)表的文獻(xiàn)。若您在當(dāng)月已發(fā)表SCI文章,但未被我公司收集,請致電Bioss,我們將贈予現(xiàn)金鼓勵,金額標(biāo)準(zhǔn)請參考“發(fā)文章 領(lǐng)獎金”活動頁面。

近期收錄2022年12月引用Bioss產(chǎn)品發(fā)表的文獻(xiàn)共273篇(圖一,綠色柱),文章影響因子(IF) 總和高達(dá)1724.643,其中,10分以上文獻(xiàn)29篇(圖二)。

圖一

 

圖二



 

本文主要分享引用Bioss產(chǎn)品發(fā)表文章至Nature NanotechnologyImmunityCancer Cell等期刊的6篇 IF>15 的文獻(xiàn)摘要,讓我們一起欣賞吧。

 


 

IMMUNITY [IF=43.474]



文獻(xiàn)引用抗體:bs-6197R

Anti-TIM4 pAb

作者單位:美國德克薩斯大學(xué)西南醫(yī)學(xué)中心免疫學(xué)系

摘要:Obesity-induced chronic liver inflammation is a hallmark of nonalcoholic steatohepatitis (NASH)—an aggressive form of nonalcoholic fatty liver disease. However, it remains unclear how such a low-grade, yet persistent, inflammation is sustained in the liver. Here, we show that the macrophage phagocytic receptor TREM2, induced by hepatocyte-derived sphingosine-1-phosphate, was required for efferocytosis of lipid-laden apoptotic hepatocytes and thereby maintained liver immune homeostasis. However, prolonged hypernutrition led to the production of proinflammatory cytokines TNF and IL-1β in the liver to induce TREM2 shedding through ADAM17-dependent proteolytic cleavage. Loss of TREM2 resulted in aberrant accumulation of dying hepatocytes, thereby further augmenting proinflammatory cytokine production. This ultimately precipitated a vicious cycle that licensed chronic inflammation to drive simple steatosis transition to NASH. Therefore, impaired macrophage efferocytosis is a previously unrecognized key pathogenic event that enables chronic liver inflammation in obesity. Blocking TREM2 cleavage to restore efferocytosis may represent an effective strategy to treat NASH.

 

ADVANCED MATERIALS

 [IF=32.086]


文獻(xiàn)引用抗體:bs-0162R

Anti-iNOS pAb
作者單位:香港大學(xué)李嘉誠醫(yī)學(xué)院骨科及創(chuàng)傷科

摘要:Conferring catalytic defects in sonosensitizers is of paramount importance in reinforcing sonodynamic therapy. However, the formation of such 0D defects is governed by the Schottky defect principle. Herein, 2D catalytic planar defects are designed within Ti3C2 sheets to address this challenge. These specific planar slip dislocations with abundant Ti3+ species (Ti3C2-SD(Ti3+)) can yield surface-bound O due to the effective activation of O2, thus resulting in a substantial amount of1O2 generation and the 99.72% ± 0.03% bactericidal capability subject to ultrasound (US) stimulation. It is discovered that the 2D catalytic planar defects can intervene in electron transfer through the phonon drag effect—a coupling effect between surface electrons and US-triggered phonons—that simultaneously contributes to a dramatic decrease in O2 activation energy from 1.65 to 0.06 eV. This design has achieved a qualitative leap in which the US catalytic site has transformed from 0D to 2D. Moreover, it is revealed that the electron origin, electron transfer, and visible O2 activation pathway triggered by US can be attributed to the phonon–electron coupling effect. After coating with neutrophil membrane (NM) proteins, the NM-Ti3C2-SD(Ti3+) sheets further demonstrate a 6-log10 reduction in methicillin-resistant Staphylococcus aureus burden in the infected bony tissue.

 

 

 


 

ADVANCED MATERIALS

 [IF=32.086]


文獻(xiàn)引用抗體:

bs-0812RAnti-IL-1 Beta pAb

bsm-33207MAnti-TNF alpha mAb
作者單位:溫州醫(yī)科大學(xué)眼科醫(yī)院眼科視光學(xué)院

摘要:Photodynamic therapy (PDT) is commonly used in choroidal neovascularization (CNV) treatment due to the superior light transmittance of the eye. However, PDT often leads to surrounding tissue damage and further microenvironmental deterioration, including exacerbated hypoxia, inflammation, and secondary neovascularization. Herein, Pt nanoparticles (NPs) and Au NPs decorated zeolitic imidazolate framework-8 (ZIF-8) nanoplatform is developed to load indocyanine green (ICG) for precise PDT and microenvironment amelioration, which can penetrate the internal limiting membrane through Müller cells endocytosis and target to CNV by surface grafted cyclo(Arg-Gly-Asp-d-Phe-Lys) after intravitreal injection. The excessive H2O2 in the CNV microenvironment is catalyzed by catalase-like Pt NPs for hypoxia relief and enhanced PDT occlusion of neovascular. Meanwhile, Au NPs show significant anti-inflammatory and anti-angiogenesis properties in regulating macrophages and blocking vascular endothelial growth factor (VEGF). Compared with verteporfin treatment, the mRNA expressions of hypoxia-inducible factor-1α and VEGF in the nanoplatform group are downregulated by 90.2% and 81.7%, respectively. Therefore, the nanoplatform realizes a comprehensive CNV treatment effect based on the high drug loading capacity and biosafety. The CNV treatment mode developed in this work provides a valuable reference for treating other diseases with similar physiological barriers that limit drug delivery and similar microenvironment.

This article is protected by copyright. All rights reserved


 

 

JOURNAL OF MEDICAL VIROLOGY

 [IF=20.693]


文獻(xiàn)引用抗體:

bs-1264RAnti-RSV G pAb

bs-6670RAnti-IGF2R/M6PR pAb

bs-0227RAnti-IGF1R pAb

作者單位:中南大學(xué)湘雅醫(yī)學(xué)院醫(yī)學(xué)微生物學(xué)系

摘要:Respiratory syncytial virus (RSV) is one of the main pathogens of viral pneumonia and bronchiolitis in infants and young children and life-threatening diseases among infants and young children. GTPases of the immune-associated protein family (GIMAP) are new family members of immune-associated GTPases. In recent years, much attention has been paid to the function of the GIMAP family in coping with infection and stress. Gimap5 is a member of the GIMAP family, which may be correlated with anti-infectious immunity. RT-qPCR, Western blot, and indirect immunofluorescence (IFA) were used to detect the expression of Gimap5, M6PR and IGF1R(the major RSV receptor). Transmission electron microscopy (TEM) was used to detect the degradation of RSV in Gimap5-overexpressed or -silent cell lines. Computer virtual screening was used to screen small molecule compounds targeting Gimap5 and the anti-RSV effects were explored through in vivo and in vitro experiments. GIMAP5 and M6PR were significantly downregulated after RSV infection. Gimap5 accelerated RSV degradation in lysosomes by interacting with M6PR, and further prevented RSV invasion by downregulating the expression of RSV surface receptor IGF1R. Three small molecule compounds targeting Gimap5 were confirmed to be the agonists of Gimap5. The three compounds effectively inhibited RSV infection and RSV-induced complications. Gimap5 promotes the degradation of RSV and its receptor through interacting with M6PR. Gimap5 agonists can effectively reduce RSV infection and RSV-induced complication in vivo and in vitro, which provides a new choice for the treatment of RSV.

 

ACS Nano [IF=18.027]


文獻(xiàn)引用抗體:bs-4947R

Anti-IL-1 Alpha pAb

作者單位:湖南長沙中南大學(xué)湘雅醫(yī)院眼科中心

摘要:Glaucoma is the leading cause of irreversible blindness worldwide, characterized by progressive vision loss due to the selective damage to retinal ganglion cells (RGCs) and their axons. Oxidative stress is generally believed as one key factor of RGCs death. Recently, necroptosis was identified to play a key role in glaucomatous injury. Therefore, depletion of reactive oxygen species (ROS) and inhibition of necroptosis in RGCs has become one of treatment strategies for glaucoma. However, existing drugs without efficient drug enter into the retina and have controlled release due to a short drug retention. Herein, we designed a glaucomatous microenvironment-responsive drug carrier polymer, which is characterized by the presence of thioketal bonds and 1,4-dithiane unit in the main chain for depleting ROS as well as the pendant cholesterols for targeting cell membranes. This polymer was adopted to encapsulate an inhibitor of necroptosis, necrostatin-1, into nanoparticles (designated as NP1). NP1 with superior biosafety could scavenge ROS in RGCs both in vitro and in vivo of an acute pathological glaucomatous injury model. Further, NP1 was found to effectively inhibit the upregulation of the necroptosis pathway, reducing the death of RGCs. The findings in this study exemplified the use of nanomaterials as potential strategies to treat glaucoma.


 

ACS Nano [IF=18.027]


文獻(xiàn)引用抗體:

bs-0061RAnti-beta-Actin (Loading Control) pAb

bs-5913RAnti-Calreticulin pAb

bs-0295G-HRPGoat Anti-Rabbit IgG H&L / HRP

作者單位:韓國成均館大學(xué)藥學(xué)院

摘要:As an emerging anticancer strategy, ferroptosis has recently been developed in combination with current therapeutic modalities to overcome the existing limitations of conventional therapies. Herein, an ultraviolet (UV) upconversion luminescence-fueled nanoreactor is explored to combine ferroptosis and apoptosis through the UV-catalyzed Fenton reaction of an iron supplement (ferric ammonium citrate) loaded in a mesoporous silica layer in addition to the support of a chemotherapeutic agent (cisplatin) attached on the functionalized silica surface for the treatment of triple negative breast cancer (TNBC). The nanoplatform can circumvent the low penetration depth typical of UV light by upconverting near-infrared irradiation and emitting UV photons that convert Fe3+ to Fe2+ to boost the generation of hydroxyl radicals (·OH), causing devastating lipid peroxidation. Apart from DNA damage-induced apoptosis, cisplatin can also catalyze Fenton-based therapy by its abundant production of hydrogen peroxide (H2O2). As a bioinspired lipid membrane, the folate receptor-targeted liposome as the coating layer offers high biocompatibility and colloidal stability for the upconversion nanoparticles, in addition to prevention of the premature release of encapsulated hydrophilic compounds, before driving the nanoformulation to the target tumor site. As a result, superior antitumor efficacy has been observed in a 4T1 tumor-bearing mouse model with negligible side effects, suggesting that such a nanoformulation could play a pivotal role in effective apoptosis-strengthened ferroptosis TNBC therapy.

※ 點(diǎn)擊這里查看往期單月Bioss抗體產(chǎn)品文獻(xiàn)引用列表

 

五月婷婷综合中文字幕| 啪啪成人影视av| 亚州一级黄色片乱伦| 99国产精品无码久久久久久| 亚洲AV中文无码字幕色三| 日韩精品人妻中文字幕第一页| 高清无码免费视频| 黄色网址视频在线播放| 亚洲高清无码AAA久久久精品| 亚欧色性爱视频| 欧美国产日韩成人| 高清国产在线拍揄自揄视频| 久久性爱免费送| 色日韩999| 东京av无卡热毛片| 欧美国产中文| 99国产无码99久久久久久| 寂寞的少妇一区二区三区八区| 国产日韩一级不卡视频| 亚洲精品嫩草| 91免费操逼逼操| 国产在线视频不卡| 亚洲国产中文午夜福利| 成人乱人乱一区二区三区一级视频| 综合激情综| 久久久久久免费网| 日韩人妻精品一区二区三区视频在线| 国产精品国产免费观看| 伊人网污版网站| 99精品视频在线播放免费| 中文字幕日韩精品亚洲一区| 久久香蕉精品久久久综合香蕉尹人综合网 | 国产AV无码专区亚洲AV手机麻豆| 伊人婷婷六月在线| 国产婷婷| 久久婷婷亚洲中文字幕| 精品内射一区二区三区| 亚洲一区二区无码伊人蜜桃| 一级婬片60分钟试免费| 亚洲精品国产精品国自产观看| 国产福利一区二视频播放24p|